ASTS
AST SpaceMobile, Inc.
ASTS has a slight edge over EGAN overall, supported by stronger modeled upside and stronger fundamentals.
EGAN
eGain Corporation
EGAN has lower modeled downside risk, despite its lower overall score.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
EGAN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Unavailable |
EGAN's cash flow is currently strong, and its revenue and profitability are stable. There isn't enough data to rate its balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
EGAN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $4.69 | -23% |
| Current | 22x | $6.10 | — |
| Fair | 46x | $14.59 | +139% |
| Expensive | 67x | $21.53 | +253% |
Historical ranges are pointers, not guarantees.
EGAN's PE is 22x, but its earnings don't support one, so it isn't a reliable read right now.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
EGAN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Stable | |
| Strongly weakening | |
| Limited | |
| High |
Analysts expect EGAN's earnings and profitability to decline, with its revenue holding steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
EGAN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $0.32 | -72% |
| Q1 2026 | $1.36 | +1411% |
| Q4 2025 | $1.27 | +807% |
| Q3 2025 | $1.21 | +537% |
| Q2 2025 | $1.13 | +352% |
| Q1 2025 | $0.09 | -68% |
| Q4 2024 | $0.14 | -36% |
| Q3 2024 | $0.19 | +27% |
EGAN has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over EGAN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
EGAN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $22.2M | -4.7% |
| Q1 2026 | $22.5M | +7.1% |
| Q4 2025 | $23M | +2.6% |
| Q3 2025 | $23.5M | +7.8% |
| Q2 2025 | $23.2M | +3.4% |
| Q1 2025 | $21M | -6% |
| Q4 2024 | $22.4M | -6% |
| Q3 2024 | $21.8M | -9.8% |
EGAN's revenue grew through 2021 and has held roughly level since: $22M last quarter, down 4.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 4.9% | -9.1 points |
| Q1 2026 | 8.9% | +8.8 points |
| Q4 2025 | 8.9% | +6 points |
| Q3 2025 | 12% | +9.7 points |
| Q2 2025 | 14% | +8.7 points |
| Q1 2025 | 0.1% | -4.1 points |
| Q4 2024 | 2.9% | -7.3 points |
| Q3 2024 | 2.3% | -3.5 points |
EGAN has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
EGAN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $2.3M | +$6.9M |
| Q1 2026 | -$1.9M | -189% |
| Q4 2025 | $9.9M | +57% |
| Q3 2025 | $10.2M | +1108% |
| Q2 2025 | -$4.5M | +$631K |
| Q1 2025 | $2.1M | +21% |
| Q4 2024 | $6.3M | -17% |
| Q3 2024 | $845K | -90% |
EGAN has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
EGAN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -279K shares |
| 1 year | -2.8% | -789K shares |
| 3 years | -15% | -4.9M shares |
| 5 years | -15% | -4.7M shares |
| Available history | -13% | -4M shares |
EGAN has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $10.1M |
| Q1 2026 | — |
| Q4 2025 | $31,000 |
| Q3 2025 | $1.5M |
| Q2 2025 | $3.8M |
| Q1 2025 | $5M |
| Q4 2024 | $2.4M |
| Q3 2024 | $4.6M |
EGAN spent $12M buying back its own shares over the past year, down 27% from the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
EGAN Net Leverage
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
EGAN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.7 | Neutral |
| Stochastic | 37.3 | Neutral |
EGAN's weekly RSI is 45 (neutral) and its Stochastic is 37 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
EGAN PE vs Technology Sector
| Metric | EGAN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 28x | 22% below |
| PE % | 24 | 35 | 11 pts below |
EGAN is trading at 22x earnings, a 22% discount to the Technology sector's median of 28x, though its earnings don't support one.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
EGAN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.78 | 5.5% above |
| 20 week MA | $6.25 | 2.4% below |
| 50 week MA | $7.74 | 21% below |
| 100 week MA | $7.43 | 18% below |
| 200 week MA | $7.09 | 14% below |
EGAN has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 14% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
EGAN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.11 | $12.6 | +55% |
| 2021 | $12.6 | $10.2 | -19% |
| 2022 | $10.2 | $8.85 | -13% |
| 2023 | $8.85 | $8.33 | -5.9% |
| 2024 | $8.33 | $6.29 | -24% |
| 2025 | $6.29 | $10.5 | +67% |
| 2026 YTD | $10.5 | $6.10 | -42% |
EGAN has the edge over ASTS on returns for 2026, with the stronger performance.